Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top

Cancer Microenvironment

Issue 1/2019

Content (7 Articles)

Metastasis Editorial

Editorial Comment: Deciphering the “Metastasome” Leads to Novel Hypotheses on Understanding the Evolution of Metastasis and Implicates Consequences for Metastasis Therapy and Prevention

Heike Allgayer

Lymphoma Review

The Tumor Microenvironment in Post-Transplant Lymphoproliferative Disorders

Lukas Marcelis, Thomas Tousseyn

Review

Mechanobiology of Cancer Stem Cells and Their Niche

Ankit Roy Choudhury, Surabhi Gupta, Pradeep Kumar Chaturvedi, Neeraj Kumar, Deepak Pandey

Original Article

Peripheral Blood Cell Interactions of Cancer-Derived Exosomes Affect Immune Function

Heather R. Ferguson Bennit, Amber Gonda, James R. W. McMullen, Janviere Kabagwira, Nathan R. Wall

Original Article

Cancer-Associated Fibroblasts Enhance Survival and Progression of the Aggressive Pancreatic Tumor Via FGF-2 and CXCL8

Mohammad Awaji, Mitsuru Futakuchi, Tayla Heavican, Javeed Iqbal, Rakesh K. Singh

Glioblastoma Original Article

Targeting Hyaluronan Interactions for Glioblastoma Stem Cell Therapy

Joline S. Hartheimer, Seungjo Park, Shreyas S. Rao, Yonghyun Kim

Esophagitis Short Communication

Altered T Cell Migratory Capacity in the Progression from Barrett Oesophagus to Oesophageal Adenocarcinoma

Maria E. Kavanagh, Melissa J. Conroy, Niamh E. Clarke, Niamh T. Gilmartin, Ronan Feighery, Finbar MacCarthy, Dermot O’Toole, Narayanasamy Ravi, John V. Reynolds, Jacintha O’ Sullivan, Joanne Lysaght

Dec 18
Issue: 2-3/2018
Dec 19
Issue: 2-3/2019

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits